{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T21:59:13Z","timestamp":1717797553351},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:00:00Z","timestamp":1350518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T00:00:00Z","timestamp":1350518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/jhh.2012.42","type":"journal-article","created":{"date-parts":[[2012,10,18]],"date-time":"2012-10-18T09:28:51Z","timestamp":1350552531000},"page":"321-327","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study"],"prefix":"10.1038","volume":"27","author":[{"suffix":"III","given":"T W","family":"Littlejohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S W","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D L","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,18]]},"reference":[{"key":"BFjhh201242_CR1","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206\u20131252.","journal-title":"Hypertension"},{"key":"BFjhh201242_CR2","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","volume":"27","author":"G Mancia","year":"2009","unstructured":"Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121\u20132158.","journal-title":"J Hypertens"},{"key":"BFjhh201242_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.hjh.0000202812.72341.99","volume":"24","author":"M Azizi","year":"2006","unstructured":"Azizi M, Webb R, Nussberger J, Hollenberg NK . Renin inhibition with aliskiren: where are we now, and where are we going? J Hypertens 2006; 24: 243\u2013256.","journal-title":"J Hypertens"},{"key":"BFjhh201242_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(10)62003-X","volume":"377","author":"MJ Brown","year":"2011","unstructured":"Brown MJ, McInnes GT, Cherif PC, Zhang J, MacDonald TM . Aliskiren and the calcium channel blocker amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. Lancet 2011; 377: 312\u2013320.","journal-title":"Lancet"},{"key":"BFjhh201242_CR5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/sj.jhh.1001683","volume":"18","author":"B Williams","year":"2004","unstructured":"Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004; 18: 139\u2013185.","journal-title":"J Hum Hypertens"},{"key":"BFjhh201242_CR6","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/1097-0258(20000830)19:16<2079::AID-SIM535>3.0.CO;2-I","volume":"19","author":"HM Hung","year":"2000","unstructured":"Hung HM . Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials. Stat Med 2000; 19: 2079\u20132087.","journal-title":"Stat Med"},{"key":"BFjhh201242_CR7","unstructured":"Braun-Dullaeus RC, Zhang J, Hristoskova S, Haring DA, Liao W . First-line therapy with aliskiren\/amlodipine combination provides robust blood pressure reductions in patients with moderate to severe hypertension. J Clin Hypertens 2010; 12 (Suppl 1): abstract 27 PO-22."},{"key":"BFjhh201242_CR8","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1185\/03007990902785845","volume":"25","author":"TW Littlejohn","year":"2009","unstructured":"Littlejohn TW, Trenkwalder P, Hollanders G, Zhao Y, Liao W . Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension. Curr Med Res Opin 2009; 25: 951\u2013959.","journal-title":"Curr Med Res Opin"},{"key":"BFjhh201242_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.109.139816","volume":"55","author":"AK Gupta","year":"2010","unstructured":"Gupta AK, Arshad S, Poulter NR . Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010; 55: 399\u2013407.","journal-title":"Hypertension"},{"key":"BFjhh201242_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/ajh.2008.367","volume":"22","author":"NR Shah","year":"2009","unstructured":"Shah NR, Hirsch AG, Zacker C, Wood GC, Schoenthaler A, Ogedegbe G et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens 2009; 22: 392\u2013396.","journal-title":"Am J Hypertens"},{"key":"BFjhh201242_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1161\/STROKEAHA.108.522193","volume":"40","author":"FZ Kettani","year":"2009","unstructured":"Kettani FZ, Dragomir A, Cote R, Roy L, Berard A, Blais L et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40: 213\u2013220.","journal-title":"Stroke"},{"key":"BFjhh201242_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2796.2009.02084.x","volume":"266","author":"S Perreault","year":"2009","unstructured":"Perreault S, Dragomir A, White M, Lalonde L, Blais L, Berard A . Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med 2009; 266: 207\u2013218.","journal-title":"J Intern Med"},{"key":"BFjhh201242_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ajh.2009.210","volume":"23","author":"PH Wu","year":"2010","unstructured":"Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC . Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens 2010; 23: 155\u2013160.","journal-title":"Am J Hypertens"},{"key":"BFjhh201242_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1524-6175.2007.06614.x","volume":"9","author":"W Drummond","year":"2007","unstructured":"Drummond W, Munger MA, Rafique EM, Maboudian M, Khan M, Keefe DL . Antihypertensive efficacy of the oral direct renin inhibitor aliskiren as add-on therapy in patients not responding to amlodipine monotherapy. J Clin Hypertens 2007; 9: 742\u2013750.","journal-title":"J Clin Hypertens"},{"key":"BFjhh201242_CR15","doi-asserted-by":"crossref","unstructured":"Black HR, Weinberger MH, Purkayastha D, Lee J, Israel M, Hilkert R et al. Combination aliskiren\/amlodipine is more effective than amlodipine monotherapy in male and female African American subjects with stage 2 hypertension. J Clin Hypertens 2010; 12 (Suppl 1): abstract 26 PO-20.","DOI":"10.1097\/01.hjh.0000378510.80205.f0"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jhh201242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201242","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jhh201242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T19:24:05Z","timestamp":1647545045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jhh201242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,18]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFjhh201242"],"URL":"https:\/\/doi.org\/10.1038\/jhh.2012.42","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,18]]},"assertion":[{"value":"12 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J Zhang, H Hsu and DL Keefe are employees of Novartis Pharmaceuticals Corporation and are therefore eligible for Novartis stock and stock options. The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}